Category Archives: Uncategorized

While there is still much work to be done in combating America’s opioid epidemic, it is important to recognize where progress has been made. A recent report by the IQVIA INSTITUTE shows that the prescribing of opioids for pain management declined by nearly 8% in 2017. In fact, opioid prescriptions have been declining since they peaked in 2011. Additionally, those who are receiving opioid prescriptions are being prescribed lower dosages and for shorter periods of time than in previous years. Along with an increase in the general awareness of the risk for opioid misuse, the report points out that 24 states have set strict limits on the length and dosage of new opioid prescriptions. It appears that messaging and new guidelines related to the risk of opioid dependence are having a real impact on the prescribing habits of doctors.

At the same time that new opioid prescriptions are declining, Medication-Assisted Treatment (MAT) participation has seen a significant increase. MAT includes the administration of FDA approved medications along with support services, such as counseling, for a comprehensive approach to treatment. This form of treatment is considered the gold standard of care for opioid use disorder. Since the start of 2016, new prescriptions for the purpose of MAT have nearly doubled. IQVIA’s report credits the rise in new MAT starts, in part, to increased funding for MAT programs.

These trends are certainly encouraging. However, plenty of challenges remain before the tide is likely to turn in our country’s struggle with opioid addiction. The prevalence of opioid prescriptions is still extremely high when compared to historical levels or with other countries. Moreover, despite a recent spike in MAT participation, the vast majority of individuals struggling with opioid addiction are still not receiving the comprehensive care they need.

View the original IQVIA report here: https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022

Behavioral Health Group (BHG) is committed to removing barriers to treatment and providing the best possible care for those struggling with opioid addiction.  We understand that opioid addiction is a chronic brain disease, not a moral failure. BHG provides comprehensive treatment for opioid addiction with over 40 locations across 11 states. We are especially excited for the opportunity to participate in grant programs at our Louisiana, Alabama, North Carolina and Kansas treatment centers. These grant programs allow qualified individuals to receive treatment at no cost.

As the opioid epidemic continues to grow at an alarming rate in America, we are beginning to better understand the role that opioid prescriptions play in contributing to this problem. A recent article from the British Medical Journal titled “Postsurgical prescriptions for opioid naïve patients and association with overdose and misuse: retrospective cohort study” highlights an important issue facing doctors and patients today. This study shows a clear correlation between the length of time a person was prescribed opioids and the likelihood of misuse.

The research outcomes demonstrates that each additional week of prescribed opioid use post-discharge was associated with a 34.2% increase in the rate of misuse. This did not seem to follow the same risk related to the dose. The actual dose prescribed only became important with extended use. My conclusions from this point toward my continued opinion that surgeons and dentist should be very conservative in their postoperative prescribing as there is clear evidence pointing to significant risk of opioid misuse and addiction with prolonged prescriptions.

This study adds to the growing research  that for  for most general procedures surgeons should try to limit prescriptions to one week or less after the procedure or discharge and then provide no more than 1 additional week of post-operative opioid medications without extenuating circumstances. This should help limit new cases of opioid addiction developing and strengthen the push to more non-narcotic methods of pain relief.

U.S. Surgeon General Visits Behavioral Health Group Knoxville Treatment Center

KNOXVILLE, Tenn., June 22, 2016 /PRNewswire/ — In an effort to combat the ever growing rates of opioid addiction in America, the U.S. Surgeon General has launched a multi-faceted campaign to help “Turn the Tide” and roll back the devastating toll on families and communities across the country.

Through a combination of educating prescribers about the opioid epidemic and mobilizing them to improve prescribing practices, the U.S. Surgeon General hopes to curb the epidemic of opioid abuse in America in a meaningful way by providing the public with information to protect themselves and their families and shifting the way we view addiction through on-site visits with staff and patients. During his recent visit to Knoxville, U.S. Surgeon General Vivek Murthy met with local provider Behavioral Health Group (BHG) in an effort to further understand the status of treatment services in an area afflicted with some of the highest per-capita rates of opiate addiction in America.

The U.S. Surgeon General first toured the Ailor Intake Center, where he had an opportunity to engage with the staff charged with discerning between a patient who is appropriate for treatment, and one who may need a different level of care. Derek Walsh, Regional Vice President with BHG, elaborated on the entry requirements – “In order to be considered appropriate for treatment, a patient must meet stringent Federal and State requirements, in addition to our assessment of their medical condition and overall stability.” The Tennessee Department of Mental Health and Substance Abuse Services estimates that approximately 70,000 Tennesseans may qualify for outpatient treatment for opiate addiction.

In touring BHG’s Knoxville Citico Treatment Center Medication Room, Nursing Supervisor Haley Green described for the U.S. Surgeon General the practice of perpetually assessing the patient to ensure medical stability: “Every interaction we have with the patient is an opportunity for us to assess the appropriateness of his/her medical care.” Ensuring that each patient is medically stabilized at the lowest possible dose of either methadone or buprenorphine is a critical component of BHG’s focus on safe and effective treatment.

Fielding questions from local media, the U.S. Surgeon General highlighted the need for expanded access to care, and how critical provider education is to ensure that this epidemic can be curtailed. “Addiction is a chronic illness….not a moral failing or a character flaw,” Murthy said. “We have to shift how we think about addiction, because until we do that, it’s going to be hard for us to, ultimately, get treatment for those who need it.”

BHG Regional Vice President Jeremy Wilkerson echoed the Surgeon General’s remarks to local media – “BHG is delivering high quality medical care in the form of Medication Assisted Treatment (MAT), which is the industry recognized “Gold Standard” for the treatment of this disease.”

About Behavioral Health Group

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 38 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

For media inquiries, contact:
Derek Walsh
214-365-6133

For prospective patients, contact:
BHG Intake Call Center
214-365-6146
www.bhgrecovery.com

To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/us-surgeon-general-visits-behavioral-health-group-knoxville-treatment-center-300288965.html

To view the article on Yahoo Finance, visit: http://finance.yahoo.com/news/u-surgeon-general-visits-behavioral-210100272.html

BHG Receives Approved Education Provider Status

Behavioral Health Group (BHG) receives Approved Education Provider Status

Dallas, Texas – September ##, 2013Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG has received authorization from NAADAC, the Association for Addiction Professionals, to grant continuing education credits for its learning and development programs to its licensed drug abuse counselors. The NAADAC Approved Education Provider program highlights BHG’s commitment to quality education and dedication to excellence.

 

The NAADAC Approved Education Provider status identifies BHG’s internal learning and development programs as meeting stringent, nationally approved standards of education developed for the drug abuse counseling field. “As a private provider of opioid addiction treatment services, this authorization as a NAADAC Approved Education Provider represents a significant effort by our Learning and Development department to provide high-quality, relevant, and applicable training programs for our staff; and demonstrates our commitment to drive continuous improvement in all we do,” added James Draudt, BHG President and Chief Operating Officer.

 

Chance Spiker, BHG’s Director of Learning and Development, said, “We strive to ensure that our professional staff of licensed addiction counselors are provided consistent, reliable and quality learning experiences that will benefit not only our internal team members, but the patients and communities we serve. This authorization from NAADAC ensures that the continuing education credits provided by BHG to its team members will be accepted toward national credentialing by the National Certification Commission for Addiction Professionals as well as many individual state licensing/credentialing bodies. This is a significant accomplishment for BHG and we are proud to be recognized by NAADAC for our efforts.”

 

BHG expects to begin providing continuing education hours to its team members beginning in October.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 30 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-276-2808 ext. 224. DebbieF@Creativetechresources.com

BHG Acquires Opioid Treatment Program in Fort Collins, Colorado

Behavioral Health Group (BHG) Acquires Opioid Treatment Program (OTP) in Fort Collins, Colorado

Dallas, Texas – October 8, 2013 – Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced the acquisition of North Colorado Behavioral Health, an opioid treatment program (OTP) located in Fort Collins, Colorado. Mr. Cannizzaro said, “We are pleased to welcome the Fort Collins staff and patients to the BHG experience of care. This strategic acquisition demonstrates our commitment to continually build relationships with the communities that we serve, while meeting our overall growth plans to serve individuals suffering from opioid addiction.”

 

Dwight Mussleman, BHG Chief Development Officer, said, “BHG now owns and operates three treatment centers in Northern Colorado. The addition of Fort Collins brings the total number of facilities in our Company network of opioid treatment programs to 31. James Draudt, BHG President and Chief Operating Officer, added, “There are numerous patients to be served throughout Northern Colorado. We are proud to add this program to our Colorado presence that currently includes centers in Denver and Boulder.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-­‐chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 31 outpatient treatment centers across the Midwest/South/Southeast/West, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-­‐365-­‐6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-­‐276-­‐2808 ext. 224. DebbieF@Creativetechresources.com

BHG New Medication Option

Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients

DALLAS, May 8, 2013 — /PRNewswire/ — Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs.

 

Mr. Cannizzaro said, “BHG’s outpatient opioid addiction treatment centers address each patient’s physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill development. This expanded service offering demonstrates our commitment to helping each individual patient achieve his/her best functional level in the community.”

 

Kelly Clark, MD, BHG Chief Medical Officer, commented, “Since most patients will be clinically appropriate for either Buprenorphine or Methadone medication, the choice of which medication each patient will try will usually be decided by the patient in consultation with his/her physician. Most patients will do well on either medication, while a few will only do well on one or the other. This additional medication option offers a choice for patients, especially those with medical conditions.”

 

BHG’s mission is to achieve positive patient outcomes by using medication-assisted treatment at the lowest possible medication dosage combined with behavioral therapy to control medical and behavioral signs of opioid addiction within an outpatient setting.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6187, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

BHG CMO Announcement

Behavioral Health Group Announces Appointment of Kelly Clark, MD, MBA as Chief Medical Officer

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced the appointment of Kelly J. Clark, MD, MBA, as Chief Medical Officer. Dr. Clark joined BHG July 9, 2012.

 

Dr. Clark joins BHG with a wide breadth and depth of both clinical and administrative experience. She has practiced addiction medicine and psychiatry throughout the continuum of care, and taught addiction treatment as a faculty member of the University of Massachusetts. She comes to BHG having most recently worked to integrate medical and behavioral health care management as Medical Director at CDPHP. She serves as President of the Kentucky Society of Addiction Medicine, where she has practiced medicine for several years and served as Medical Director of a number of Opioid Treatment Programs.

 

“I am thrilled to join BHG in the work of providing excellent treatment services to those patients suffering under the epidemic of opioid addiction,” said Clark. “This disease is ravaging individual lives and entire communities across the country. BHG is uniquely situated to bring best practice medication assisted treatment to thousands of patients, and I am excited to work to increase access to evidence-based, physician-directed, team-delivered, high-quality care”.

 

A Phi Beta Kappa graduate of Coe College in Cedar Rapids, Iowa, Kelly holds a Doctor of Medicine degree from the University of Wisconsin, and a Master of Business Administration with Additional Certification in Health Sector Management from the Fuqua School of Business at Duke University. She is currently on the faculty of the Virginia Tech Carillion School of Medicine. Dr. Clark is a Fellow of the American Society of Addiction Medicine, where she serves as a Director, and is a Distinguished Fellow of the American Psychiatric Association.

 

BHG’s Chairman and CEO, Michael N. Cannizzaro, said of the appointment: “The Board is delighted to welcome Kelly to BHG’s executive team as Chief Medical Officer. Her talents and experiences will be invaluable in directing the pharmacotherapy and behavioral therapy aspect of our business as she builds the Medical Directorate of our company.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit https://bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt, COO

BHG CEO Announcement

Behavioral Health Group Announces Transition of CEO Andrew Love to Advisory Role; Board Appoints Chairman, Mike Cannizzaro, as Chairman and CEO

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced that Andrew Love has stepped down as Chief Executive Officer and Director and has transitioned to a consulting role with the Company as he pursues a new opportunity. He is succeeded by Michael N. Cannizzaro, BHG’s Chairman.

 

Andy said of his transition: “It was an honor to build and lead BHG from inception to its sale a year ago to the Frontenac Company. I am delighted to continue working together with the leadership team of professionals at BHG and Frontenac, and I am grateful for the support I’ve received from the Board of Directors and our team members over the last six years as we have built BHG into a leader in the field of opioid addiction treatment.”

 

Mr. Love added, “BHG’s growth will undoubtedly accelerate under the outstanding and experienced leadership of Mike Cannizzaro, with whom I have enjoyed working over the last year. I look forward to my continued support of BHG as a co-founder, advisor, and shareholder.”

 

BHG’s Chairman and CEO, Mike Cannizzaro, said: “The Board expresses its gratitude to Andy for his dedicated service to BHG since co-founding the company in 2006, and we thank him for the vision and leadership he brought to the company. We are delighted that we will be able to draw on Andy’s talents and experience through his participation as an advisor to the Company. We wish him every success in his future endeavors.”

 

Mike Cannizzaro, Chairman and CEO, has 36 years of leadership experience in healthcare companies, including Baxter Healthcare, Caremark International, Beltone Electronics, National Nephrology, and Sunrise Medical, to name a few. He was also an operating partner of JW Childs Associates, a leading private equity firm based in Boston.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit https://bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt

BHG Tennessee Announcement

Behavioral Health Group (BHG) Acquires Opioid Treatment Program in Tennessee

Dallas, Texas – May 7, 2013 – Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced the acquisition of an opioid treatment program (OTP) in Central Tennessee located in Columbia. “We are pleased to welcome the Columbia staff and patients to the BHG experience of care. This strategic acquisition demonstrates our commitment to continually build relationships with the communities that we serve, while meeting our overall growth plans to serve individuals suffering from opioid addiction.”

 

Dwight Mussleman, BHG Chief Development Officer, said, “There are numerous patients to be served throughout Central Tennessee. We are proud to add this program to our Tennessee presence that currently includes centers in Jackson, Knoxville, Memphis, Nashville and Paris.”

 

Denise Woodie, Program Director, said, “Our treatment center staff is excited to be a part of the BHG family. We have enjoyed working with the BHG executive team through this transition and found this integration process to be smooth and uncomplicated. Becoming part of the BHG network of treatment centers allows us to leverage both the organization’s resources and knowledge to deliver excellent patient care and enhanced support to ensure that our patients progress efficiently through their recovery process.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-276-2808 ext. 224. DebbieF@Creativetechresources.com